
The FDA has warned Novartis that three North American production facilities operated by its generics subsidiary Sandoz are failing to …
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics

